72.11.Z - Research and experimental development on biotechnology
20.14.Z - Manufacture of other organic basic chemicals
20.59.Z - Manufacture of other chemical products not elsewhere classified
21.10.Z - Manufacture of basic pharmaceutical substances
32.50.Z - Manufacture of medical and dental instruments and supplies
62.01.Z - Computer programming activities
72.19.Z - Other research and experimental development on natural sciences and engineering
74.90.Z - Other professional, scientific and technical activities not elsewhere classified
86.90.E - Other human health activities notelsewhere classified
2021 | 2022 | 2023 | ||
---|---|---|---|---|
M PLN | M PLN | M PLN | % | |
Profit (loss) on sale | 0 | -0 | -0 | -395,7 |
Gross profit (loss) | -0 | -0 | -0 | -395,7 |
EBITDA | -0 | -0 | -0 | -395,7 |
Short time liabilities | 0 | 0 | 0 | -∞ |
Other operating costs | 0 | 0 | 0 | 0 |
Income tax | ||||
Equity capital | 0 | 0 | 0 | -13,4 |
Operating profit (EBIT) | -0 | -0 | -0 | -395,7 |
Cash | 0 | 0 | 0 | -3 |
Net income from sale | 0 | 0 | 0 | 0 |
Liabilities and provisions for liabilities | 0 | 0 | 0 | -∞ |
Working assets | 0 | 0 | 0 | -3 |
Other income costs | 0 | 0 | 0 | 0 |
Depreciation | 0 | 0 | 0 | 0 |
Basic operational activity income | ||||
% | % | % | p.p. | |
Profitability of capital | -1 | -2,7 | -15,5 | -12,8 |
Equity capital to total assets | 100 | 100 | 89,3 | -10,7 |
Days | Days | Days | Days | |
Short term commitment turnover cycle | 0 | 0 | 2 147 483 648 | 2 147 483 648 |
Current financial liquidity indicator | 9.347000122070312 | |||
Net dept to EBITDA | 98.4035873413086 | 36.9869499206543 | 7.235640048980713 | -29,8 |
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane